| |
|
|
|
|
|
|
|||
|
Blood, 13 August 2009, Vol. 114, No. 7, pp. 1445-1453. Prepublished online as a Blood First Edition Paper on May 11, 2009; DOI 10.1182/blood-2009-01-199323.
TRANSPLANTATION Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimerasDepartments of 1 Immunology, 2 Surgery, and 3 Pediatrics, 4 Cancer and Leukemia Group B Statistical Center, and 5 Department of Medicine, Duke University Medical Center, Durham, NC Severe combined immunodeficiency (SCID) is a syndrome of diverse genetic cause characterized by profound deficiencies of T, B, and sometimes NK-cell function. Nonablative human leukocyte antigen–identical or rigorously T cell–depleted haploidentical parental bone marrow transplantation (BMT) results in thymus-dependent genetically donor T-cell development in the recipients, leading to long-term survival. We reported previously that normal T-cell numbers, function, and repertoire developed by 3 to 4 months after transplantation in SCID patients, and the repertoire remained highly diverse for the first 10 years after BMT. The T-cell receptor diversity positively correlated with T-cell receptor excision circle levels, a reflection of thymic output. However, the fate of thymic function in SCID patients beyond 10 to 12 years after BMT remained to be determined. In this greater than 25-year follow-up study of 128 patients with 11 different molecular types of SCID after nonconditioned BMT, we provide evidence that T-cell function, thymic output, and T-cell clonal diversity are maintained long-term.
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||